Lung cancer is the leading cause of cancer death in Japan and Western countries (Levi et al., 1996) . Lung caner can be divided into four major histological subtypes, including squamous cell carcinoma, adenocarcinoma, large cell carcinoma, and small cell carcinoma (SCLC) (Carney et al., 1985) . SCLC is distinguished from the other three histological subtypes (non-SCLC) by its distinct histological appearance and early metastasis to lymph nodes, the central nervous system, bone and other sites (Carney et al., 1985; Shimosato et al., 1986) . Although cancer metastasis is a multifactorial biological phenomenon, disrupted cell adhesion and enhanced cell motility are considered to be pivotal (Behrens et al., 1992) . Histopathologically, SCLC is characterized by scant cytoplasm and a high nuclear/ cytoplasmic ratio (Arora et al., 2003) . SCLC cells are known to be fragile and highly susceptible to the mechanical force applied during biopsy procedures (Arora et al., 2003) . SCLC cells in culture adhere poorly to the plastic surface and often grow in suspension (Carney et al., 1985) . Based on these observations, we hypothesized that SCLC may contain abnormalities in the actin cytoskeleton, because the status of actin directly affects cellular morphology, solidity, adhesion, and motility (Small et al., 1999; Hirohashi and Kanai, 2003) .
The actin cytoskeleton is regulated by various kinds of actin-binding proteins. We previously isolated aactinin-4 as a novel actin-binding protein (Honda et al., 1998) . Increased expression and altered subcellular localization of actinin-4 were associated with cell motility and cancer metastasis (Honda et al., 1998; Araki et al., 2000) . Reduced expression of actinin-4 is reportedly associated with cell adhesion abnormalities in neuroblastoma cell lines (Nikolopoulos et al., 2000) .
Status of the actin cytoskeleton and actinin-4 protein in SCLC
To evaluate the above hypothesis, we first examined the status of the actin cytoskeleton and actinin-4 protein in SCLC (five cases) and non-SCLC (10 cases) by fluorescence immunohistochemistry (Figure 1a-i) . In acetone-fixed and paraffin-embedded tissues, filamentous actin polymers appeared to be well preserved and were stained in vivo with fluorescence-labeled phalloidin. The cortical actin cytoskeleton uniformly underlined cell membranes in all 10 non-SCLC cases (red, squamous cell carcinoma, Figure 1a and adenocarcinoma, Figure 1d ). However, the actin cytoskeleton of SCLC was irregularly interrupted or fragmented and the staining intensity was not uniform (red, Figure 1g ).
The actinin-4 protein was dissociated from the cortical actin cytoskeleton and translocated into the nucleus in all SCLC cases (Figure 1h and i). Immunoblotting revealed no significant gross alterations in actinin-4 or b-actin proteins extracted from SCLC and non-SCLC cell lines (Figure 1j ).
Identification of the alternative splice variant of actinin-4
We next sequenced nearly the entire coding region of actinin-4 cDNA obtained from two SCLC cell lines, H69 and H231. We noticed a mixture of two different sequences appearing in nucleotides 793-872 (NM_004924.2) (top, Figure 2a ). The two transcripts were separately cloned and their nucleotide sequences were determined (Ub and Va, Figure 2a ). One transcript (Ub, hereafter, ubiquitous type, Figure 2a ) was the same sequence as one we previously reported (Honda et al., 1998) and the other (Va, variant type, Figure 2a) was distinct from the formerly described sequence of the actinin-4 transcript.
Comparison of the nucleotide sequence of the variant transcript with the genomic sequence of actinin-4 (ACTN4, NT_011109.15) revealed RNA alternative splicing to apparently be responsible for generation of the variant transcript. The 83-bp exon 8 of the actinin-4 gene was replaced by a new exon of the same size (8 0 )
that exists in intron 8 (Figure 2b ). This is a putative exon based on its being flanked by conserved splicing acceptor and donor sequences (data not shown). No mutation in the region of exon/intron boundaries of exons 8, 8 0 , and 9 was detected by sequencing genomic DNA of H69 and N231 cells (data not shown).
The nucleotide change in the variant transcript was predicted to produce a new restriction site for BanII. The presence or absence of the variant transcript was determined in a larger panel of samples by digesting PCR products of actinin-4 cDNA with BanII Figure 2c ) or normal lung (data not shown).
Although the new exon 8 0 had sequence similarity to the usual exon 8 (62/83, 74.4%), the variant type was predicted to encode a polypeptide differing from ubiquitous type in three amino acids (Figure 2d ): asparagine (amino acid 248, NP_004915) to glycine, alanine (250) to leucine, and serine (262) to cysteine. Kaplan et al. (2000) reported the missense mutations in exon 8 of the actinin-4 gene in three familial focal segmental glomerulosclerosis (FSGS) families and this mutation was confirmed to be causative for FSGS in an animal model (Michaud et al., 2003) . The three altered amino-acid sites seen in the splice variant of actinin-4 were adjacent to those of point mutations reported in FSGS (Figure 2d ).
In-vitro actin-binding activity of variant actinin-4
The actinin-4 protein with the missense mutation in exon 8 in FSGS has been reported to have a high affinity to filamentous actin polymers. We compared the actinbinding activity of ubiquitous and variant types of recombinant actinin-4 proteins, including the minimal actin-binding and pleckstrin-homology (PH) domains and splicing sites (Figure 3a ). After incubation with filamentous actin polymers, insoluble materials were precipitated with ultracentrifugation and examined by immunoblotting with anti-actinin-4 rabbit polyclonal antibody (top, Figure 3b ). Like mutant actinin-4 in FSGS, the variant actinin-4 bound to filamentous actin 2, Figure 3b ). In the absence of actin polymers, actinin-4 was not precipitated (lanes 3 and 4) . Precipitated filamentous actin polymers and input recombinant actinin-4 proteins were almost equivalent as shown by coomassie blue staining (middle, Figure 3b ) and immunoblotting with anti-actinin-4 antibody (bottom, Figure 3b ), respectively.
Functional properties of variant actinin-4
Finally, to gain insight into the functional properties of variant actinin-4, we compared the subcellular localization of two types of actinin-4. We transiently transfected NIH 3T3 cells with variant and ubiquitous types of near full-length actinin-4 cDNA constructs tagged NH2-terminally with enhanced green fluorescence protein (EGFP) (Figure 4a-f) . Ubiquitous type actinin-4 was co-localized with cortical filamentous actin bundles in membrane ruffling, especially at the periphery of leading edges (Figure 4a and green, 4c) . In contrast, the splice variant of actinin-4 was not concentrated along the cell membrane and was found to be co-localized mainly with actin stress fibers (Figure 4d and green, 4f) . As revealed by phalloidin staining, stress fiber formation appeared to be enhanced in cells transfected with the variant construct of actinin-4 (Figure 4e and red, 4f) , probably because of its higher filamentous actin polymer crosslinking activity. The dissociation from cortical actin is consistent with the results of the above immunohistochemical analyses (Figure 1a-i) , but we observed no nuclear translocation of exogenously expressed variant actinin-4 in NIH3T3 cells.
Concluding remarks
Alternative RNA splicing may affect the native functions of proteins. a-Actinin is a family of proteins that bind and crosslink filamentous actin polymers (Djinovic-Carugo et al., 2002) . The sites of deduced aminoacid alterations of variant actinin-4 in SCLC were close to those of point mutations in FSGS. Variant actinin-4 protein showed higher affinity to filamentous actin polymers than ubiquitous actinin-4 (Figure 3b ), similar to that of mutant actinin-4 in FSGS (Kaplan et al., 2000) . As actinin must exist as a head-to-tail dimer to cross-like actin polymers (Djinovic-Carugo et al., 2002) , the presence of a small amount of abnormal molecules may affect the overall function of actinin homodimers. In fact, a hemizygous missense mutation of the actinin-4 gene is dominantly inherited in FSGS families (Kaplan et al., 2000) . SCLC showed translocation of the entire actinin-4 protein into the nucleus, even in the presence of normal actinin-4 molecules (Figure 1g-i) .
In addition to abnormalities of actinin-4, we observed fragility of the actin cytoskeleton to be characteristic of SCLC (Figure 1g-i) . Dysregulation of the actin cytoskeleton appears to be an adequate explanation for small cell size, cell fragility and the aggressive behavior of SCLC. However, the NIH3T3 cells expressing exogenous variant actinin-4 protein showed no evidence of cell collapse or nuclear translocation of actinin-4 ( Figure  4d-f) , but rather showed intensification of actin stress fibers (Figure 4e and red, Figure 4f ). We do not presently know whether the expression of variant actinin-4 protein with different actin binding is a result or a cause of the abnormal actin cytoskeleton of SCLC.
Alternative RNA splicing variants with tumor-specificity may be applied for cancer diagnosis and selective treatment. An accurate differential diagnosis of SCLC from non-SCLC is critical for the selection of therapy against lung cancer. Detection of the variant RNA of actinin-4 might provide a good diagnostic marker for SCLC patients.
Expression of the variant actinin-4 was essentially limited to SCLC and testis. Recently, a large number of autoantigens recognized by the host immune system in cancer patients were found to be molecules expressed exclusively in malignant tissues and the testis. These The actinbinding activity of purified actinin-4 proteins was analysed using an Actin Binding Protein Biochem kit (Cytoskeleton, Acoma, CO, USA). Briefly, 2 mg of recombinant proteins of ubiquitous (lanes 1 and 3) and variant (lanes 2 and 4) actinin-4 were incubated with (lanes 1 and 2) or without (lanes 3 and 4) 23 mM filamentous actin polymers at room temperature for 30 min and sedimented at 1.5 Â 10 5 g for 1.5 h at 241C. Precipitated actinin-4 proteins are detected by immunoblotting with anti-actinin-4 polyclonal antibody (top). Coomassie blue staining and immunoblotting reveal the equivalent precipitation of filamentous actin polymers (middle) and the equivalent input of actinin-4 proteins (bottom), respectively, in lanes 1 and 2 so-called CT antigens (cancer-testis antigens) have been recognized as good candidate targets for cancer immunotherapy, because the testis is naturally protected from cytotoxic T lymphocytes (CTL) (dos Santos et al., 2000) . Several CT antigens are currently being tested as tumor vaccines in clinical trials (Jager et al., 1999) . Recently, Echchakir et al. identified an antigen, which was specifically recognized by an autologous tumorspecific CTL clone derived from mononuclear cells infiltrating the primary non-SCLC, as a mutated form of actinin-4. The patient showed a favorable clinical course, probably because of the active immune response against autologous tumor cells expressing the mutant actinin-4 (Echchakir et al., 2001) . Variant actinin-4 is a potential target molecule for immunotherapy against SCLC.
